Anthropic has acquired AI biotech startup Coefficient Bio for roughly $400 million, according to a person with knowledge of the deal.

The startup’s team will be joining Anthropic’s health care life sciences group, which is aimed at developing tools for biotech workflows ranging from drug discovery to clinical commercialization, said the person.

Coefficient Bio, started last fall, was developing a platform that enables AI to run biotech tasks such as planning drug research and development, managing clinical regulatory strategy, and identifying new drug opportunities. The company’s cofounders include CEO Aris Theologis and Chief Technology Officer Nathan Frey.